UMIN000048637Recruiting
Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer
Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of ToyamaNot ApplicableUniversity Hospital Medical Information NetworkdeviceDevice trial
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- breast cancer
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Aug 15, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048637
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048637 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama and is currently Recruiting. The study focuses on breast cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.